IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells

Journal of Molecular Endocrinology

Volumn 41, Issue 1-2, 2008, Pages 65-74

  Chang, Mu Hsin ^a,b   Kuo, Wei Wen ^c   Chen, Ray Jade ^d   Lu, Ming Chin ^c   Tsai, Fuu Jen ^c   Kuo, Wu Hsien ^e   Chen, Ling Yun ^b   Wu, Wen Jun ^b,c   Huang, Chih Yang ^c,f   Chu, Chun Hsien ^b,c  

^a TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAICHUNG HOSPITAL   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; LEUCINE; SMALL INTERFERING RNA; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL CELL; ARTICLE; BLAST CELL; CONTROLLED STUDY; ENZYME ACTIVITY; HEART CELL CULTURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; CELL LINE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MATRIX METALLOPROTEINASE 9; PLASMINOGEN ACTIVATORS; RECEPTOR, IGF TYPE 2; RECEPTORS, SOMATOMEDIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TISSUE PLASMINOGEN ACTIVATOR; TRANSFECTION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 51349127269     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-08-0051     Document Type: Article

References (29)

1. Berk BC, Fujiwara K & Lehoux S 2007 ECM remodeling in hypertensive heart disease. Journal of Clinical Investigation 117 568-575.
2. Beukers MW, Oh Y, Zhang H, Ling N & Rosenfeld RG 1991 [Leu27] insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, cross-linking and thymidine incorporation experiments. Endocrinology 128 1201-1203.
3. Chen Z, Ge Y & Kang JX 2004 Doxon-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes. BMC Cell Biology 5 15.
4. Cleutjens JP & Creemers EE 2002 Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction. Journal of Cardiac Failure 8 S344-S348.
5. Deschamps AM & Spinale FG 2006 Pathways of matrix metalloproteinase induction in heart failure: bioactjve molecules and transcriptional regulation. Cardiovascular Research 69 666-676.
6. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P et al. 2000 Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. Journal of Clinical Investigation 106 55-62.
7. Fay WP 2004 Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury. Trends in Cardiovascular Medicine 14 196-202.
8. Gaertner R, Jacob MP, Prunier F, Angles-Cano E, Mercadier JJ & Michel JB 2005 The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat. Journal of Molecular and Cellular Cardiology 38 193-204.
9. Gallagher GL, Jackson CJ & Hunyor SN 2007 Myocardial extra cellular matrix remodeling in ischemic heart failure. Frontiers in Bioscience 12 1410-1419.
10. Ghosh P, Dahms NM & Kornfeld S 2003 Mannose 6-phosphate receptors: new twists in the tale. Nature Reviews. Molecular Cell Biology 4 202-212.
11. Godar S, Horejsi V, Weidle UH, Binder BR, Hansmann C & Stockinger H 1999 M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. European Journal of Immunology 29 1004-1013.
12. Hawkes C, Jhamandas JH, Harris KH, Fu W, MacDonald RG & Kar S 2006 Single transmembrane domain insulin-like growth factor-II/ mannose-6-phosphate receptor regulates central cholinergic function by activating a G-protein-sensitive, protein kinase C-dependent pathway. Journal of Neuroscience 26 585-596.
13. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A et al. 1999 Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nature Medicine 5 1135-1142.
14. Heymans S, Lupu F, Terclavers S, Vanwetswinkel B, Herbert JM, Baker A, Collen D, Carmeliet P & Moons L 2005 Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. American Journal of Pathology 166 15-25.
15. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16 3-34.
16. Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P & Stewart CL 1994 Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes and Development 8 2953-2963.
17. Leask A & Abraham DJ 2004 TGF-beta signaling and the fibrotic response. FASEB Journal 18 816-827.
18. Lee SD, Chu CH, Huang EJ, Lu MC, Liu JY, Liu CJ, Hsu HH, Lin JA, Kuo WW & Huang CY 2006 Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. American Journal of Physiology. Endocrinology and Metabolism 291 E306-E314.
19. Li YY, McTiernan CF & Feldman AM 2000a Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovascular Research 46 214-224.
20. Li H, Simon H, Bocan TM & Peterson JT 2000b MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition. Cardiovascular Research 46 298-306.
21. Lijnen HR, Silence J, Lemmens G, Frederix L & Collen D 1998 Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thrombosis and Haemostasis 79 1171-1176.
22. McKinnon T, Chakraborty C, Gleeson LM, Chidiac P & Lala PK 2001 Stimulation of human extra villous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. Journal of Clinical Endocrinology and Metabolism 86 3665-3674.
23. Nishimoto I, Hata Y, Ogata E & Kojima I 1987 Insulin-like growth factor II stimulates calcium influx in competent BALB/ c 3T3 cells primed with epidermal growth factor. Characteristics of calcium influx and involvement of GTP-binding protein. Journal of Biological Chemistry 262 12120-12126.
24. Odekon LE, Blasi F & Rifkin DB 1994 Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. Journal of Cellular Physiology 158 398-407.
25. Peterson JT, Hallak H, Johnson L, Li H, O'Brien PM, Sliskovic DR, Bocan TM, Coker ML, Etoh T & Spinale FG 2001 Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103 2303-2309.
26. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL & Quigley JP 1999 Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. Journal of Biological Chemistry 274 13066-13076.
27. Schultz GA, Hahnel A, Arcellana-Panlilio M, Wang L, Goubau S, Watson A & Harvey M 1993 Expression of IGF ligand and receptor genes during preimplantation mammalian development. Molecular Reproduction and Development 35 414-420.
28. Spinale FG 2002 Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circulation Research 90 520-530.
29. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, Goldberg AT, Zellner JL & Crumbley AJ 2000 A matrix metalloproteinase induction/ activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 102 1944-1949.